Company profile

SK Chemicals

285130 · KOSPI

Public Market Listing

285130KOSPI

KOSPI primary exchange listing

Live quotes, historical charts, and market capitalization for SK Chemicals are available on Yahoo Finance.

External market data link · No third-party exchange redistribution

Assets

(1 total)

1Total Assets

0Approved

1Phase 3 / Filed

0Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
cilostazol/Ginkgo biloba(Rinexin)No recent activity	Phase 3	PDE3 inhibitor (cilostazol) + herbal adjunct (Ginkgo biloba)Small molecule	Atherosclerotic Cardiovascular Disease

Research

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Research

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.